Home
Conference Highlights
View All Conference Highlights
Year in Review / Wrap-Ups
Wrap-Ups
Year in Review
Contact Us
Year in Review
Sanjiv S. Agarwala, MD
Professor
Temple University School of Medicine
Philadelphia, PA
Authored Items
Benefits of Dual I-O Therapy in Metastatic Uveal Melanoma
By
Sanjiv S. Agarwala, MD
Dual IO 2021 - Year in Review
Dual IO 2021 - Year in Review
The combination of nivolumab and ipilimumab offers deep and sustained responses and improved overall survival in malignant uveal melanoma.
Read More ›
Dual Immune Checkpoint Inhibitors in Advanced Cutaneous Melanoma
By
Sanjiv S. Agarwala, MD
Dual IO 2021 - Year in Review
Dual IO 2021 - Year in Review
Dual immunotherapy provides significant and durable benefits as first-line treatment and as neoadjuvant therapy in advanced melanoma.
Read More ›
Home
Conference Highlights
View All Conference Highlights
Year in Review / Wrap-Ups
Wrap-Ups
Year in Review
Contact Us